Navigation Links
Pradaxa Side Effect Warning: Pradaxa Label to Warn Blood-Thinner Shouldn’t be Used in People with Mechanical Heart Valves, Bernstein Liebhard LLP Reports
Date:12/22/2012

New York, NY (PRWEB) December 22, 2012

A new Pradaxa side effect warning has been announced by Boehringer Ingelheim, the maker of the blood thinner, Bernstein Liebhard LLP reports. According to an alert issued by U.S. Food & Drug Administration (FDA) on December 19th, the company will be modifying the Pradaxa label to warn that it should not be prescribed to patients who have had a mechanical prosthetic heart valve replacement. Boehringer Ingelheim will also be sending a “Dear Doctor Letter” to healthcare providers to inform them of this new contraindication. The change follows the halt of RE-ALIGN trial, which was ended because Pradaxa users were more likely to experience strokes, heart attacks, and blood clots forming on the mechanical heart valves than were users of warfarin. There was also more bleeding after valve surgery in the Pradaxa users than in the warfarin users, the FDA said.

“This new contraindication is just another reminder that Pradaxa side effects, including internal bleeding, can be quite serious,” says Bernstein Liebhard LLP, a national law firm representing clients who have been injured by dangerous drugs and defective medical devices. The firm is currently offering free and confidential Pradaxa lawsuit evaluations to patients who were allegedly harmed by this drug.

Pradaxa Lawsuits
Pradaxa is used to prevent strokes in people with a heart-rhythm disorder known as atrial fibrillation. According to a recent report from Bloomberg.com, internal bleeding is a potential Pradaxa side effect for which there is no readily available antidote. The FDA received reports of 542 deaths and 3,781 side-effect incidents tied to the drug in 2011. Bloomberg also reported that the Institute of Safe Medication Practices has found Pradaxa has generated more reports of injury or death than any of the 800 drugs it monitors.

According to Bloomberg, 150 Pradaxa lawsuits are now pending in a federal multidistrict litigation currently underway in U.S. District Court, Southern District of Illinois. All of the complaints allege plaintiffs suffered serious, life-threatening episodes of internal bleeding, and that the company sold the blood thinner despite knowing it could cause fatal bleeding in some patients. (In Re: Pradaxa (Dabigatran Etexilate) Products Liability Litigation – MDL No. 2385)

Victims of serious Pradaxa side effects may be eligible to collect compensation for their medical bills, lost wages, pain and suffering and more. To learn more about filing a Pradaxa lawsuit, please visit our website http://www.consumerinjurylawyers.com/, or call 1-877-779-1414 to speak with one of our attorneys today.

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.

10 East 40th Street
New York, New York 10016
(877) 779-1414

ATTORNEY ADVERTISING. © 2012 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. The lawyer responsible for this advertisement in the State of Connecticut is Amy L. Abate. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

###
Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com
http://www.consumerinjurylawyers.com

Read the full story at http://www.prweb.com/releases/pradaxa-side-effect/pradaxa-lawsuit/prweb10265923.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Approval of Safer Alternative to Pradaxa Delayed by FDA
2. Pradaxa Maker Working on Antidote Amid Pradaxa Bleeding Warnings
3. FDA: Dont Use Pradaxa Blood Thinner in Patients With Artificial Heart Valves
4. Young girls more likely to report side effects after HPV vaccine
5. Preteens More Likely to Report HPV Vaccine Side Effects
6. In children born with severe heart defect, surgical management has little effect on neuro outcomes
7. Novel compound demonstrates anti-leukemic effect in zebrafish, shows promise for human treatment
8. Breast cancer patients suffer treatment-related side effects long after completing care
9. Breast Cancer Treatment Side Effects May Last for Years
10. Baldness Drug May Cause Sexual Side Effects: FDA
11. Study examines adverse effects among different radiation therapies for prostate cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida attorneys are recognized ... this recognition are considered among the top 2 percent of lawyers practicing within the ... this year’s Legal Elite Hall of Fame: Miami Shareholders Mark D. Bloom, Burt ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, ... and the Road To Recovery® program to drive cancer patients to and from their ... to ensure the highest quality of life and ongoing independence. Getting to and ...
(Date:6/24/2016)... Plano, TX (PRWEB) , ... June 24, 2016 , ... ... taking part in Genome magazine’s Code Talker Award, an essay contest in which patients ... for an award to be presented at the 2016 National Society of Genetic Counselors ...
(Date:6/24/2016)... York, NY (PRWEB) , ... June 24, 2016 ... ... publication Haute Living, is proud to recognize Dr. Barry M. Weintraub as a ... that “the most beautiful women in the world, and the most handsome men, ...
(Date:6/24/2016)... ... June 24, 2016 , ... Strategic Capital Partners, LLC (SCP) ... obtaining investment capital for emerging technology companies. SCP has delivered investment events ... in more than a million dollars of capital investment for five companies. ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Ill. , June 23, 2016  In a startling report ... are failing their residents by lacking a comprehensive, proven plan to ... a definitive ranking of how states are tackling the worst ... to only four states – Kentucky , ... Vermont . Of the 28 failing states, three ...
(Date:6/23/2016)... Research and Markets has announced the ... 2016 - Forecast to 2022" report to their offering. ... up to date financial data derived from varied research sources ... with potential impact on the market during the next five ... comprises of sub markets, regional and country level analysis. The ...
(Date:6/23/2016)... June 23, 2016 Research and Markets ... Issue 52" report to their offering. ... treatment creates a favourable commercial environment for MedImmune to enter. ... base that will serve to drive considerable growth for effective ... serve to cap sales considerably, but development is still in ...
Breaking Medicine Technology: